Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study to Determine the Relationships Between Survival and FIGO Stage, Tumour Volume and Corpus Invasion in Cervical Cancer

NCT00193934 is registered in ClinicalTrials.gov with Trans Tasman Radiation Oncology Group as lead sponsor.

NCT NCT00193934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00193934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study to Determine the Relationships Between Survival and FIGO Stage, Tumour Volume and Corpus Invasion in Cervical Cancer
Lead sponsor
Trans Tasman Radiation Oncology Group
Phase
Observational
Overall status
Completed
Start date
January 31, 2006
Completion date
May 15, 2014
Enrollment
109 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the uterine cervix